The genetically engineered mouse model will be utilised to test whether blockade of STAT3 in earlier stages of NF1-associated nerve sheath tumour progression in plexiform neurofibroma and/or MPNST may have utility in MPNST chemoprevention. The gene discussed is NF1; the disease is nerve sheath neoplasm.